Dunjin Chen: Clinical Trials

6 trials sponsored by Dunjin Chen, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 unknown, 1 not yet recruiting. 1 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable1Not yet recruiting 1

Follow Dunjin Chen: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Effectiveness of a Care Bundle to Prevent Postpartum Hemorrhage After Cesarean Delivery
A care bundle - Cesarean Delivery
Not applicableNot yet recruitingDunjin Chen520002025-01-012025-01-01
Inflammatory Biomarkers for the Diagnosis of oPRES
Whether the PE or E patient combined with PRES - Posterior Reversible Encephalopathy Syndrome, Inflammatory Biomarkers
CompletedDunjin Chen6212022-07-012022-08-03
The Predictors of ICU Admission of oPRES
Whether the patient needs to be admitted to the ICU - Posterior Reversible Encephalopathy Syndrome, Intensive Care Units
CompletedDunjin Chen3662022-04-012022-06-14
Long-term Consequences of Neuroimaging and Perceived Cognitive Dysfunction in oPRES
neuroimaging examination,neuro-cognitive test,blood pressure,blood sample - Neuroimaging, Cognitive Dysfunction
UnknownDunjin Chen5002022-01-012021-12-08
Effects of Recurrent PE on Women and Offspring
blood pressure,BMI, blood sample - Preeclampsia, Recurrence
UnknownDunjin Chen10002022-01-012021-12-08
The Clinical and Prognostic Features of PRES
PRES in PE or E - Posterior Reversible Encephalopathy Syndrome, Pregnancy Outcomes
CompletedDunjin Chen3542020-10-012022-03-02

Conditions studied

Posterior Leukoencephalopathy Syndrome (4)  ·  Pre-Eclampsia (2)  ·  Cognitive Dysfunction (1)  ·  Eclampsia (1)  ·  Hypertension (1)  ·  Postpartum Hemorrhage (1)  ·  Recurrence (1)

Interventions

Pressure (2)  ·  Blood Specimen Collection (1)

Countries

China (5)